ArticleJTO clinical and research reports2026
Tumor Mass Is a Better Prognostic Factor Than Consolidation-to-Tumor Ratio in Invasive Lung Adenocarcinoma Manifest Difficult-to-Measure Solid Portion.
Article in JTO clinical and research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Tumor Burden Index to Predict the Prognosis in Stage IA Lung Adenocarcinoma.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the long-term prognosis and related factors in patients who manifest part-solid invasive lung adenocarcinoma with difficult-to-measure solid portions. Methods: Patients with resected clinical stage I part-solid invasive lung adenocarcinoma in a single institution were retrospectively enrolled. They were divided into measurable and difficult-to-measure groups according to whether the radiologically solid portion was difficult to measure. The Kaplan-Meier method was used to evaluate the outcomes. Cox analysis was used to explore the prognostic factors. Tumor nodules were segmented using 3D Slicer software to extract quantitative features. Results: Of the 1240 patients, 225 (18.2%) were classified into the difficult-to-measure group. The intraclass correlation coefficient revealed that two readers had an excellent agreement on solid size in the measurable group (0.88), but not in the difficult-to-measure group (0.65). Compared with the measurable group, these tumors were larger and exhibited comparable overall survival (10 y 95.0% versus 94.2%; Conclusions: Patients with invasive adenocarcinoma manifesting as part-solid nodules whose solid components were difficult to measure revealed favorable outcomes. Tumor mass was a better prognostic indicator than consolidation-to-tumor ratio for this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.